Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 617-35-6 Chemical Structure| 617-35-6

Structure of Ethyl pyruvate
CAS No.: 617-35-6

Chemical Structure| 617-35-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ethyl pyruvate is a simple aliphatic ester of pyruvic acid and has been shown to have robust neuroprotective effects via its anti-inflammatory, anti-oxidative, and anti-apoptotic functions.

Synonyms: CTI-01

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ethyl pyruvate

CAS No. :617-35-6
Formula : C5H8O3
M.W : 116.12
SMILES Code : CC(C(OCC)=O)=O
Synonyms :
CTI-01
MDL No. :MFCD00009123
InChI Key :XXRCUYVCPSWGCC-UHFFFAOYSA-N
Pubchem ID :12041

Safety of Ethyl pyruvate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H225
Precautionary Statements:P501-P210-P233-P370+P378-P303+P361+P353-P403+P235
Class:3
UN#:3272
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
murine cholangiocytes (mCL) 2.5 µg 16 hours inhibited RRV-induced HMGB1 secretion Hepatology. 2021 Aug;74(2):864-878
rat spinal cord astrocytes 12 μM 6, 12, 24 hours HMGB1 inhibition reduced OGD/R-induced cellular swelling and AQP4 upregulation J Neuroinflammation. 2017 Nov 25;14(1):231
DLBCL cell lines (Su-DHL-4, Su-DHL-8, Su-DHL-10, OCI-Ly7, TMD8, OCI-Ly3, Su-DHL-2) 2 mM 24 and 48 hours EP significantly inhibited the proliferation of DLBCL cells by blocking the HMGB1-mediated Src/ERK signaling pathway and the G1 to S phase transition of the cell cycle. Cell Death Dis. 2019 Apr 15;10(5):330
N9 microglial cells 10 mM 1 hour EP significantly suppressed LPS and ATP-induced NLRP3 inflammasome activation, decreased active caspase-1 level, secretion of IL-1β and IL-18 cytokines, and reduced the level of pyroptotic cell death resulting from inflammasome activation. Furthermore, EP reduced the formation of total and mitochondrial ROS and suppressed inflammasome-induced HMGB1 upregulation and nuclear NF-κB translocation and reversed the inflammasome activation-induced miRNA expression profile for miR-223 in N9 cells. Antioxidants (Basel). 2021 May 8;10(5):745
mouse microglia 10 mM 3 hours To investigate the effect of EP on NLRP3 inflammasome activation, results showed that EP significantly inhibited NLRP3 inflammasome activation and IL-1β release. Mol Med. 2020 Jun 9;26(1):55

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rats Controlled cortical impact (CCI) injury model Intraperitoneal injection 40 mg/kg Administered at 0, 1, 3, and 6 hours post-injury EP treatment significantly altered brain metabolite profiles at 24 hours post-injury, reducing oxidative stress and inflammatory markers, and enhancing energy metabolism. J Neuroinflammation. 2024 Nov 14;21(1):294
HTau transgenic mice Tau-dependent neurodegenerative disease model Intraperitoneal injection EP (80 mg/kg) + GA (20 mg/kg) Three times per week for 8 weeks To investigate the effects of HMGB1 release inhibitors on tau pathology and cognitive functions, results showed that EP+GA treatment significantly decreased TauO and senescent cell loads in the brain, reduced neuroinflammation, and ameliorated cognitive functions. Cell Rep. 2021 Jul 20;36(3):109419
C57BL/6 mice Cecal ligation and puncture (CLP) model Intraperitoneal injection 40 mg/kg Once every 2 days during the infection period To evaluate the protective effect of EP on SAE, results showed that EP significantly attenuated CLP-induced cognitive decline, microglia activation, and impaired neurogenesis. Mol Med. 2020 Jun 9;26(1):55
Mice (Mus musculus) Lmx1bV265D mice Oral 2000 mg/kg/day Started on postnatal day 2 and continued until 6 months Pyruvate supplementation significantly mitigated elevated intraocular pressure (p=0.002) and optic nerve damage (p<0.0003). Elife. 2025 Apr 24;14:RP105576
BALB/C mice A20 cell-induced lymphoma model Intraperitoneal injection 40 and 80 mg/kg Twice daily for 30 days EP significantly prevented and inhibited lymphoma tumor growth and prolonged the survival of DLBCL-bearing mice. EP significantly downregulated HMGB1 expression and phosphorylation of Src and ERK1/2. Cell Death Dis. 2019 Apr 15;10(5):330

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

8.61mL

1.72mL

0.86mL

43.06mL

8.61mL

4.31mL

86.12mL

17.22mL

8.61mL

References

 

Historical Records

Categories